Keri Hildick

Corporate Officer/Principal at Perspectum Group Ltd.

40 year

Consumer Services

Technology Services

Profile

Keri Hildick is currently the Chief Strategy Officer at Perspectum Group Ltd.
She obtained an undergraduate degree from The University of Edinburgh and a doctorate degree from the University of Bristol.

Keri Hildick active positions

Companies	Position	Start
Perspectum Group Ltd. Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.	Corporate Officer/Principal	2015-06-30

All active positions of Keri Hildick

Training of Keri Hildick

University of Bristol	Doctorate Degree
The University of Edinburgh	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keri Hildick's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Perspectum Group Ltd. Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.	Technology Services